(Q34057579)

30 July 2017

1 reference

title

Nonsteroidal anti-inflammatory drugs. (English)

1 reference

30 July 2017

Tseng CC

1

1 reference

PubMed ID

11026931

30 July 2017

Wolfe MM

series ordinal

2

1 reference

30 July 2017

1 September 2000

1 reference

Medical Clinics of North America

30 July 2017

1 reference

30 July 2017

84

1 reference

30 July 2017

5

1 reference

30 July 2017

1329-1344

1 reference

Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Cimetidine for peptic ulcer in patients with arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

The influence of cimetidine on peptic ulcer in patients with arthritis taking anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Inducible cyclooxygenase may have anti-inflammatory properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

7 January 2021

Aspirin and the stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Cost-conscious prescribing of nonsteroidal anti-inflammatory drugs for adults with arthritis. A review and suggestions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Role of nitric oxide in the gastric cytoprotection induced by central vagal stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

The hydrophobic barrier properties of gastrointestinal mucus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Endogenous nitric oxide modulates ethanol-induced gastric mucosal injury in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Indomethacin-induced gastric injury and leukocyte adherence in arthritic versus healthy rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Resistance to medical therapy of gastric ulcers in rheumatic disease patients taking aspirin. A double-blind study with cimetidine and follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Omeprazole ameliorates aspirin-induced gastroduodenal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Recent considerations in nonsteroidal anti-inflammatory drug gastropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Nonsteroidal anti-inflammatory drugs and peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Future trends in the development of safer nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

The physiology of gastric acid secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970289-3

10.1016/S0025-7125(05)70289-3

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11026931